Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Chinook Therapeutics, Inc. (KDNY)

18.05   -0.61 (-3.27%) 06-26 22:30
Open: 18.97 Pre. Close: 18.66
High: 19.0694 Low: 17.8
Volume: 1,223,670 Market Cap: 1,112(M)
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. Its product candidates also include BION-1301, an anti-APRIL monoclonal antibody is being evaluated in a Phase I/II trial for IgA nephropathy; and CHK-336, an oral small molecule LDHA inhibitor for the treatment of primary hyperoxaluria, as well as research programs for other rare and severe chronic kidney diseases. Chinook Therapeutics, Inc. is headquartered in Seattle, Washington.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 19.11 - 19.21 19.21 - 19.28
Low: 17.55 - 17.67 17.67 - 17.77
Close: 17.88 - 18.06 18.06 - 18.21

Technical analysis

as of: 2022-06-24 4:41:11 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 22.85     One year: 26.69
Support: Support1: 15.32    Support2: 12.7
Resistance: Resistance1: 19.56    Resistance2: 22.85
Pivot: 17.51
Moving Average: MA(5): 18.54     MA(20): 17.12
MA(100): 14.76     MA(250): 14.13
MACD: MACD(12,26): 0.9     Signal(9): 0.7
Stochastic oscillator: %K(14,3): 74.3     %D(3): 80.1
RSI: RSI(14): 58
52-week: High: 19.56  Low: 10.47
Average Vol(K): 3-Month: 632 (K)  10-Days: 880 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ KDNY ] has closed below upper band by 36.8%. Bollinger Bands are 35.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 24 Jun 2022
Wall Street Analysts See a 94% Upside in Chinook (KDNY): Can the Stock Really Move This High? - Nasdaq

Wed, 22 Jun 2022
Chinook Therapeutics (NASDAQ:KDNY) swells 17% this week, taking one-year gains to 30% - Simply Wall St

Tue, 14 Jun 2022
Short Interest in Chinook Therapeutics, Inc. (NASDAQ:KDNY) Rises By 56.3% - Defense World

Fri, 10 Jun 2022
Recent Price Trend in Chinook (KDNY) is Your Friend, Here's Why - Nasdaq

Thu, 09 Jun 2022
Has DBV Technologies (DBVT) Outpaced Other Medical Stocks This Year? - Yahoo Finance

Sat, 28 May 2022
Chinook Therapeutics, Inc. (NASDAQ:KDNY) CEO Purchases $65,150.00 in Stock - MarketBeat

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 55 (M)
% Held by Insiders 4.389e+007 (%)
% Held by Institutions 1.3 (%)
Shares Short 1,430 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -7.42e+007
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) -199.4
Operating Margin (%) -153
Return on Assets (ttm) -10
Return on Equity (ttm) -26.2
Qtrly Rev. Growth 6
Gross Profit (p.s.) -0.62
Sales Per Share 0.02
EBITDA (p.s.) -2.12
Qtrly Earnings Growth -3.8
Operating Cash Flow 0 (M)
Levered Free Cash Flow -103 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio -0.5
Price to Book value 0
Price to Sales 807.95
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 1.35e+006
Dividend Yield 0%
Dividend Pay Date 2020-10-01
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.